Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / AFIB - Acutus Medical sees Q4 revenue $4.7M-$4.9M above estimates; appoints Takeo Mukai as CFO

AFIB - Acutus Medical sees Q4 revenue $4.7M-$4.9M above estimates; appoints Takeo Mukai as CFO

Acutus Medical Inc.
  • Acutus Medical ( NASDAQ: AFIB ) sees Q4 2022 revenue of ~$4.7M-$4.9M vs. consensus of $4.16M compared to $4.4M in the Q4 of 2021.
  • Excluding the proceeds associated with milestones from the left-heart access portfolio sale to Medtronic, the company expects cash burn to decline 25-30% compared to the third quarter of 2022 and 35-40% compared to the fourth quarter of 2021.
  • For the full year 2022, the company expects revenue to be in a range of $16.1M-16.3M vs. consensus of $15.71M compared to $17.3M in 2021.
  • Additionally, the company announced the appointment of Takeo Mukai as Senior Vice President and Chief Financial Officer, effective January 9, 2023.
  • Mr. Mukai, most recently served as interim Chief Financial Officer.

For further details see:

Acutus Medical sees Q4 revenue $4.7M-$4.9M above estimates; appoints Takeo Mukai as CFO
Stock Information
Company Name: Acutus Medical Inc.
Stock Symbol: AFIB
Market: NASDAQ
Website: acutusmedical.com
Menu
AFIB AFIB Quote AFIB Short AFIB News AFIB Articles AFIB Message Board
Get AFIB Alerts

News, Short Squeeze, Breakout and More Instantly...